Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer.

about

Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q55019406

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pre-treatment hemoglobin level ...... th non-small cell lung cancer.

@en

Pre-treatment hemoglobin level ...... th non-small cell lung cancer.

@nl

type

Item

label

Pre-treatment hemoglobin level ...... th non-small cell lung cancer.

@en

Pre-treatment hemoglobin level ...... th non-small cell lung cancer.

@nl

prefLabel

Pre-treatment hemoglobin level ...... th non-small cell lung cancer.

@en

Pre-treatment hemoglobin level ...... th non-small cell lung cancer.

@nl

P1476

Pre-treatment hemoglobin level ...... ith non-small cell lung cancer

@en

P2093

Hong Lu

http://www.w3.org/2001/XMLSchema#string

Meng-Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Pin Lv

http://www.w3.org/2001/XMLSchema#string

Xiang-Lei Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Zhao

http://www.w3.org/2001/XMLSchema#string

Yue-Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Yue-Min Zhou

http://www.w3.org/2001/XMLSchema#string

Yuquan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications.

Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.

Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer

Survival after surgery in stage IA and IB non-small cell lung cancer.

Molecular mechanisms underlying chronic inflammation-associated cancers.

Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

P304

44-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2018.1628

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29896399

http://www.w3.org/2001/XMLSchema#string

P932

5995083

http://www.w3.org/2001/XMLSchema#string